Similar articles

• [Current status of type A and type B monoamine oxidase (author's transl)].

  Suzuki O. Suzuki O. Seikagaku. 1980;52(3):158-62. Seikagaku. 1980. PMID: 6774035 Review. Japanese. No abstract available.
• Psychoactive drug effects and substrate-specificity in intact mitochondrial monoamine oxidase from brain [proceedings].

  Gabay S, Achee FM. Gabay S, et al. Psychopharmacol Bull. 1977 Jan;13(1):45-6. Psychopharmacol Bull. 1977. PMID: 13452 No abstract available.
• Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species.

  Squires RF. Squires RF. Adv Biochem Psychopharmacol. 1972;5:355-70. Adv Biochem Psychopharmacol. 1972. PMID: 5054207 No abstract available.
• Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.

  Inoue H, Castagnoli K, Van Der Schyf C, Mabic S, Igarashi K, Castagnoli N Jr. Inoue H, et al. J Pharmacol Exp Ther. 1999 Nov;291(2):856-64. J Pharmacol Exp Ther. 1999. PMID: 10525109
• [Recent advances in studies on the specific inhibition and nature of monoamine oxidases (review)].

  Gorkin VZ. Gorkin VZ. Vopr Med Khim. 1982 Mar-Apr;28(2):2-9. Vopr Med Khim. 1982. PMID: 6805132 Review. Russian. No abstract available.